LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

BACKGROUND: Lysosomal-associated protein transmembrane-4 beta (LAPTM4B), a novel oncogene, promotes tumorigenesis and may be a potential prognostic biomarker in several cancers. This study was to determine the clinical significance and biological roles of LAPTM4B in lung adenocarcinoma (LAC). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Meng, Yue, Zhang, Qing-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444825/
https://www.ncbi.nlm.nih.gov/pubmed/30940109
http://dx.doi.org/10.1186/s12885-019-5506-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444825/
https://www.ncbi.nlm.nih.gov/pubmed/30940109
http://dx.doi.org/10.1186/s12885-019-5506-7

Ejemplares similares